Search by Categories
- Insights
- Rare Disease
- Oncology
- Cell and Gene Therapy
- Medical Devices
- Consulting
- News & Analysis
- Therapeutic Areas
Our expertise in the industry
The treatment options for Non-Small Cell Lung Cancer (NSCLC) have been flooded in recent years due to improved methods of molecular profiling and better diagnostic tools. The new molecular b...
FDA Validates Use of Amgen’s KRAS Inhibitor in Lung Cancer In a pathbreaking move, Amgen has gone ahead to emerge as a trailblazer in the undruggable lung cancer space with the approval o...
Promega Biotech Ibérica Gains Recognition for COVID-19 Response in SpainPromega Biotech Ibérica has been heralded as the business leader in Spain for its COVID-19 response. The company’s innov...
Clover Biopharmaceuticals Raises $230 Million Clover Biopharmaceuticals announced the completion of an oversubscribed $230 million Series C financing, summing total capital raised by the ...
AZ, Daiichi put their trust into TROP2-based drugs, inks an oncology deal to together develop and commercialize DS-1062AstraZeneca has inked an oncology deal with Daiichi Sankyo to jointly de...
Over the past few decades Cancer has emerged as a major public health concern worldwide. Cancer is the second leading cause of deaths that takes place worldwide. Every sixth death is due to cancer...
Non-small cell lung cancer market is anticipated to increase in the 7MM from USD 9,730 million in 2017 by 2030.Worldwide, cancer claimed the lives of approximately 9.6 million people in 2018 ...
Bristol-Meyers Squibb and Acceleron Pharma have announced that US FDA committee will review BMS’s supplemental Biologics License Application (sBLA) for its Reblozyl in MDS.Reblozyl ((luspater...
An estimated number of 18.1 million new cancer cases were registered last year, according to A Cancer Journal for Clinicians 2018;0:1‐31. Moreover, it is a leading cause of global deaths. The deat...
The drug Imfinzi (durvalumab) has failed to come up as an effective treatment option for treating non-small cell lung cancer (NSCLC). The result of the NEPTUNE study was not much of a promising on...
In advanced cancer patients, the most common site for the occurrence of metastasis is c...
Depression is a mental condition characterized by prolonged series of poor moods, loss ...
Myasthenia Gravis is an autoimmune disease that causes muscle weakness and fatigue. It ...
West syndrome is a rare form of neurological disorder, an age-related specific Epilepti...
Chronic diseases (CDs) pose a significant challenge to healthcare in the 21st century. ...
Hear from our subject-matter experts and in-house KOL’s on Pharma and Healthcare market trends.
.png)
-Featured.png)
